Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martyn Wood

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Expert Opinion on Investigational Drugs|May 16, 2007
Aripiprazole acts as a selective dopamine D2 receptor partial agonistMartyn Wood, Charlie Reavill
The Journal of Family Planning and Reproductive Health Care|June 19, 2017
Contraception choices for transgender malesKathy Jones, Martyn Wood, Liz Stephens
International Journal of STD & AIDS|March 17, 2026
Fracture risk assessment in patients prescribed pre-exposure prophylaxis for HIV: An audit and comparative evaluation of screening toolsQuin Healey, Martyn Wood, Emily Clarke
International Journal of STD & AIDS|June 11, 2014
Outreach sexual infection screening and postal tests in men who have sex with men: are they comparable to clinic screening?Martyn Wood, Rachael Ellks, Moira Grobicki
International Journal of STD & AIDS|May 8, 2026
An evaluation of the clinical impact of serological testing for herpes simplex virus in a regional UK sexual health serviceCatriona Boyd, Martyn Wood, Emily Clarke
British Journal of Pharmacology|October 24, 2014
Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptorsMartyn Wood, Vanessa Dubois, Dieter Scheller, et al.
Sexually Transmitted Infections|October 25, 2017
BASHH HealthUnlockedRebecca Thomson-Glover, Hannah Pintilie, Jennifer Dhingra, et al.
Molecular Pharmacology|December 15, 2015
In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 ReceptorMartyn Wood, Ali Ates, Veronique Marie Andre, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2019
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABA<sub>A</sub> ReceptorMartyn Wood, Veronique Daniels, Laurent Provins, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2006
5-HT2C antagonists based on fused heterotricyclic templates: design, synthesis and biological evaluationDieter Hamprecht, Fabrizio Micheli, Giovanna Tedesco, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|May 16, 2007
Aripiprazole acts as a selective dopamine D2 receptor partial agonistMartyn Wood, Charlie Reavill
The Journal of Family Planning and Reproductive Health Care|June 19, 2017
Contraception choices for transgender malesKathy Jones, Martyn Wood, Liz Stephens
International Journal of STD & AIDS|March 17, 2026
Fracture risk assessment in patients prescribed pre-exposure prophylaxis for HIV: An audit and comparative evaluation of screening toolsQuin Healey, Martyn Wood, Emily Clarke
International Journal of STD & AIDS|June 11, 2014
Outreach sexual infection screening and postal tests in men who have sex with men: are they comparable to clinic screening?Martyn Wood, Rachael Ellks, Moira Grobicki
International Journal of STD & AIDS|May 8, 2026
An evaluation of the clinical impact of serological testing for herpes simplex virus in a regional UK sexual health serviceCatriona Boyd, Martyn Wood, Emily Clarke
British Journal of Pharmacology|October 24, 2014
Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptorsMartyn Wood, Vanessa Dubois, Dieter Scheller, et al.
Sexually Transmitted Infections|October 25, 2017
BASHH HealthUnlockedRebecca Thomson-Glover, Hannah Pintilie, Jennifer Dhingra, et al.
Molecular Pharmacology|December 15, 2015
In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 ReceptorMartyn Wood, Ali Ates, Veronique Marie Andre, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2019
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABA<sub>A</sub> ReceptorMartyn Wood, Veronique Daniels, Laurent Provins, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2006
5-HT2C antagonists based on fused heterotricyclic templates: design, synthesis and biological evaluationDieter Hamprecht, Fabrizio Micheli, Giovanna Tedesco, et al.
Pageof 4